-
Je něco špatně v tomto záznamu ?
Risk of recurrent ischemic stroke in young cryptogenic patients with embolic stroke of undetermined source
D. Šaňák, P. Divišová, M. Hutyra, M. Král, A. Bártková, J. Zapletalová, J. Látal, T. Dorňák, Š. Hudec, D. Franc, P. Polidar, T. Veverka, P. Kaňovský
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
Grantová podpora
NV17-30101A
MZ0
CEP - Centrální evidence projektů
- MeSH
- cévní mozková příhoda * diagnostické zobrazování epidemiologie etiologie MeSH
- dospělí MeSH
- embolická cévní mozková příhoda * MeSH
- intrakraniální embolie * komplikace diagnostické zobrazování epidemiologie MeSH
- ischemická cévní mozková příhoda * MeSH
- ischemie mozku * komplikace diagnostické zobrazování epidemiologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- prospektivní studie MeSH
- rizikové faktory MeSH
- senioři MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- Publikační typ
- časopisecké články MeSH
INTRODUCTION: Elderly cryptogenic ischemic stroke (IS) patients with embolic stroke of undetermined source (ESUS) have a high risk of recurrent IS (RIS) compared to other stroke subtypes. In young ESUS patients, different sources of embolism may be a cause and the risk of RIS remains not enough established. The aim was to assess and compare risk of RIS between ESUS and non ESUS patients <50 years. METHODS: The study set consisted of young acute IS patients <50 years enrolled in the prospective HISTORY (Heart and Ischemic STrOke Relationship studY) study registered on ClinicalTrials.gov (NCT01541163). In all analyzed patients, the brain ischemia was confirmed on CT or MRI. All patients underwent identical diagnostic protocol including TEE and long-term ECG-Holter. Cause of IS was assessed according to the ASCOD classification. RESULTS: Of 320 enrolled patients <50 years, 219 (68.4%) were identified as cryptogenic (119 males, mean age 41.4 ± 7.2 years) and 122 (38.1%) patients fulfilled the ESUS criteria. During the follow-up with a median of 34 months, three (2.5%) ESUS and 5 (5.2%) non-ESUS patients suffered from RIS (p = .471). One-year risk of RIS was 0.008 (95% CI: 0-0.025) for ESUS and 0.036 (95% CI: 0-0.076) for non-ESUS patients (p = .262). CONCLUSION: The risk of RIS was very low in ESUS patients and did not differ from those with non-ESUS. Our finding may indicate that antiplatelet therapy can be effective in the secondary prevention in young ESUS patients if high-risk sources of embolization are excluded extensively.
Department of Biophysics and statistics Palacký University Medical School Olomouc Czech Republic
Department of Cardiology Palacký University Medical School and Hospital Olomouc Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21020124
- 003
- CZ-PrNML
- 005
- 20211123082423.0
- 007
- ta
- 008
- 210728s2020 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jns.2020.116985 $2 doi
- 035 __
- $a (PubMed)32563078
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Šaňák, Daniel $u Comprehensive Stroke Center, Department of Neurology, Palacký University Medical School and Hospital, Olomouc, Czech Republic. Electronic address: daniel.sanak@fnol.cz
- 245 10
- $a Risk of recurrent ischemic stroke in young cryptogenic patients with embolic stroke of undetermined source / $c D. Šaňák, P. Divišová, M. Hutyra, M. Král, A. Bártková, J. Zapletalová, J. Látal, T. Dorňák, Š. Hudec, D. Franc, P. Polidar, T. Veverka, P. Kaňovský
- 520 9_
- $a INTRODUCTION: Elderly cryptogenic ischemic stroke (IS) patients with embolic stroke of undetermined source (ESUS) have a high risk of recurrent IS (RIS) compared to other stroke subtypes. In young ESUS patients, different sources of embolism may be a cause and the risk of RIS remains not enough established. The aim was to assess and compare risk of RIS between ESUS and non ESUS patients <50 years. METHODS: The study set consisted of young acute IS patients <50 years enrolled in the prospective HISTORY (Heart and Ischemic STrOke Relationship studY) study registered on ClinicalTrials.gov (NCT01541163). In all analyzed patients, the brain ischemia was confirmed on CT or MRI. All patients underwent identical diagnostic protocol including TEE and long-term ECG-Holter. Cause of IS was assessed according to the ASCOD classification. RESULTS: Of 320 enrolled patients <50 years, 219 (68.4%) were identified as cryptogenic (119 males, mean age 41.4 ± 7.2 years) and 122 (38.1%) patients fulfilled the ESUS criteria. During the follow-up with a median of 34 months, three (2.5%) ESUS and 5 (5.2%) non-ESUS patients suffered from RIS (p = .471). One-year risk of RIS was 0.008 (95% CI: 0-0.025) for ESUS and 0.036 (95% CI: 0-0.076) for non-ESUS patients (p = .262). CONCLUSION: The risk of RIS was very low in ESUS patients and did not differ from those with non-ESUS. Our finding may indicate that antiplatelet therapy can be effective in the secondary prevention in young ESUS patients if high-risk sources of embolization are excluded extensively.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 12
- $a ischemie mozku $x komplikace $x diagnostické zobrazování $x epidemiologie $7 D002545
- 650 12
- $a embolická cévní mozková příhoda $7 D000083262
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a intrakraniální embolie $x komplikace $x diagnostické zobrazování $x epidemiologie $7 D020766
- 650 12
- $a ischemická cévní mozková příhoda $7 D000083242
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a rizikové faktory $7 D012307
- 650 12
- $a cévní mozková příhoda $x diagnostické zobrazování $x epidemiologie $x etiologie $7 D020521
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Divišová, Petra $u Comprehensive Stroke Center, Department of Neurology, Palacký University Medical School and Hospital, Olomouc, Czech Republic $7 xx0266700
- 700 1_
- $a Hutyra, Martin $u Department of Cardiology, Palacký University Medical School and Hospital, Olomouc, Czech Republic
- 700 1_
- $a Král, Michal $u Comprehensive Stroke Center, Department of Neurology, Palacký University Medical School and Hospital, Olomouc, Czech Republic
- 700 1_
- $a Bártková, Andrea $u Comprehensive Stroke Center, Department of Neurology, Palacký University Medical School and Hospital, Olomouc, Czech Republic
- 700 1_
- $a Zapletalová, Jana $u Department of Biophysics and statistics, Palacký University Medical School, Olomouc, Czech Republic
- 700 1_
- $a Látal, Jan $u Department of Cardiology, Palacký University Medical School and Hospital, Olomouc, Czech Republic
- 700 1_
- $a Dorňák, Tomáš $u Comprehensive Stroke Center, Department of Neurology, Palacký University Medical School and Hospital, Olomouc, Czech Republic
- 700 1_
- $a Hudec, Štěpán $u Department of Cardiology, Palacký University Medical School and Hospital, Olomouc, Czech Republic
- 700 1_
- $a Franc, David $u Comprehensive Stroke Center, Department of Neurology, Palacký University Medical School and Hospital, Olomouc, Czech Republic
- 700 1_
- $a Polidar, Petr $u Comprehensive Stroke Center, Department of Neurology, Palacký University Medical School and Hospital, Olomouc, Czech Republic
- 700 1_
- $a Veverka, Tomáš $u Comprehensive Stroke Center, Department of Neurology, Palacký University Medical School and Hospital, Olomouc, Czech Republic
- 700 1_
- $a Kaňovský, Petr $u Comprehensive Stroke Center, Department of Neurology, Palacký University Medical School and Hospital, Olomouc, Czech Republic
- 773 0_
- $w MED00003004 $t Journal of the neurological sciences $x 1878-5883 $g Roč. 416, č. - (2020), s. 116985
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32563078 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20211123082424 $b ABA008
- 999 __
- $a ok $b bmc $g 1690834 $s 1140570
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 416 $c - $d 116985 $e 20200613 $i 1878-5883 $m Journal of the neurological sciences $n J Neurol Sci $x MED00003004
- GRA __
- $a NV17-30101A $p MZ0
- LZP __
- $a Pubmed-20210728